Money talks. Treatments get short-changed.

This pie-chart from the Policy Cures Research speaks volumes. It’s from their COVID-19 R&D TRACKER UPDATE dated 6 AUGUST 2020. They say about $8.9 billion is going toward COVID-19 R&D, and the product pipeline has at least 938 product candidates. Only 2% is going to basic research. Say what? How can products ~ especially vaccines ~ […]

Money talks. Treatments get short-changed. Read More »